Profil
Kevin Tomaselli is Acting Chief Operating Officer of Ikaria, Inc. From 2003 to 2005, he was an Executive Vice President of Operations and Chief Scientific Officer of Ascenta Therapeutics, Inc. Previously, he was Vice President of Science and Technology for Idun Pharmaceuticals, Inc. from 1993 to 2002 and co-founded the company.
Dr. Tomaselli received a PhD in Neuroscience from the University of California in 1988.
Anciens postes connus de Kevin Tomaselli
| Sociétés | Poste | Fin |
|---|---|---|
| IKARIA, INC. | Directeur des opérations | - |
Formation de Kevin Tomaselli
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
